• 8297 Citations
  • 45 h-Index
1982 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sangnae Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 8297 Citations
  • 45 h-Index
  • 257 Article
  • 7 Comment/debate
  • 6 Letter
  • 4 Review article

Construction and characterization of the mycobacterium tuberculosis sigE fadD26 unmarked double mutant as a vaccine candidate

Hernandez-Pando, R., Shin, S. J., Clark, S., Casonato, S., Becerril-Zambrano, M., Kim, H., Boldrin, F., Mata-Espinoza, D., Provvedi, R., Arbues, A., Marquina-Castillo, B., Mazzabò, L. C., Barrios-Payan, J., Martin, C., Cho, S. N., Williams, A. & Manganelli, R., 2020 Jan 1, In : Infection and Immunity. 88, 1, e00496-19.

Research output: Contribution to journalArticle

  • Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach

    Cho, Y., Park, Y., Sim, B., Kim, J., Lee, H., Cho, S. N., Kang, Y. A. & Lee, S. G., 2020 Dec 1, In : Scientific reports. 10, 1, 3825.

    Research output: Contribution to journalArticle

    Open Access
  • Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy

    Bellerose, M. M., Baek, S. H., Huang, C. C., Moss, C. E., Koh, E. I., Proulx, M. K., Smith, C. M., Baker, R. E., Lee, J. S., Eum, S., Shin, S. J., Cho, S. N., Murray, M. & Sassetti, C. M., 2019 Jul 1, In : mBio. 10, 4, e00663-19.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Citations (Scopus)

    Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects

    Hong, J. Y., Park, S. Y., Kim, A., Cho, S. N. & Hur, Y. G., 2019 Dec 1, In : Journal of Thoracic Disease. 11, 12, p. 5210-5217 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): Study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

    Lee, M., Mok, J., Kim, D. K., Shim, T. S., Koh, W. J., Jeon, D., Lee, T., Lee, S. H., Kim, J. S., Park, J. S., Lee, J. Y., Kim, S. Y., Lee, J. H., Jo, K. W., Jhun, B. W., Kang, Y. A., Ahn, J. H., Kim, C. K., Shin, S., Song, T. & 8 others, Shin, S. J., Kim, Y. R., Ahn, H., Hahn, S., Won, H. J., Jang, J. Y., Cho, S. N. & Yim, J. J., 2019 Jan 16, In : Trials. 20, 1, 57.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)